Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSeventy units of tirzepatide does not correspond to a licensed Mounjaro dose. Tirzepatide is measured in milligrams, not units (the doses are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg) and the "units" framing almost always signals confusion with insulin, which is measured that way. If you've seen a syringe marked in units and wondered how it maps to your Mounjaro pen, the short answer is: it doesn't, and it shouldn't. Mounjaro is a prescription-only medicine and the dose your prescriber sets is the only one that applies to you; the Patient Information Leaflet and your prescriber are the right sources for any specific dosing question.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The biggest misunderstanding behind this search is a reasonable one. Insulin has been measured in units for decades, and many people who manage diabetes or live with someone who does are familiar with insulin pens, syringes graduated in units, and instructions written in units. When a new injectable medicine arrives, it's natural to reach for the same mental framework.
Tirzepatide doesn't fit that framework at all. Mounjaro is supplied as a pre-filled, single-patient KwikPen, each pen contains four weekly doses, already set by the manufacturer at a fixed concentration. You do not draw up tirzepatide into a syringe. You do not count units. The pen delivers the dose when you press the button. There is no dial, no plunger, no graduation markings in units to misread.
The concern is that people who do try to draw tirzepatide from a vial into an insulin syringe (which has happened with compounded or counterfeit products) are working with a completely different concentration system and risk catastrophic dosing errors. The MHRA has warned publicly about fake weight-loss pens, and any product requiring you to measure units of tirzepatide yourself is a serious red flag. You can report suspect sellers through the MHRA Yellow Card scheme.
For insulin, one "unit" is a standardised biological measure tied to insulin's specific activity. The number of milligrams of insulin in one unit varies by formulation, but the unit itself is a consistent way to describe insulin's effect.
Tirzepatide is not insulin. It's a dual GIP and GLP-1 receptor agonist, the only one of its kind licensed for weight management in the UK. Its doses are fixed in milligrams and set by clinical trial evidence, regulatory review and SmPC licence, not converted from a unit scale. Asking how many mg is 70 units of tirzepatide is a bit like asking how many litres is 70 miles: the units belong to different systems entirely.
In the licensed Mounjaro KwikPen, tirzepatide is dissolved in a solution at a known concentration, but that concentration is irrelevant to the patient because the pen mechanism handles delivery. For a breakdown of how the milligram doses translate to the solution volume in each injection, the Mounjaro SmPC on the eMC sets this out in the pharmaceutical particulars, it's technical reading aimed at healthcare professionals, but it's publicly accessible.
If you're trying to cross-reference a 2.5 mg starting dose with the volume delivered, the page covering how many units 2.5 mg of tirzepatide represents addresses that specific question directly.
Treatment with Mounjaro starts at 2.5 mg once weekly. That dose is a tolerability step: the job of the first pen is to let your system adjust, not to deliver full therapeutic effect. From there, a prescriber typically increases by one step every four weeks or so, guided by how you're tolerating the current dose and your clinical picture. The ceiling is 15 mg.
That schedule (2.5, 5, 7.5, 10, 12.5, 15 mg) is what NICE reviewed when appraising tirzepatide in TA1026 and what the clinical trial programme tested. SURMOUNT-1, which randomised over 2,500 adults with obesity, found average body-weight reductions of around 20–21% at the 15 mg maintenance dose over 72 weeks. Those results were achieved through the licensed titration route, not through patients self-adjusting doses.
This matters for the units question. Someone wondering whether 70 units equals a particular mg dose may be trying to self-calculate an adjustment. That's not how Mounjaro works, and it's not something a prescriber would want a patient attempting. If you feel your current dose isn't working or side effects are making it hard to continue, that's a clinical conversation, the kind that happens through a consultation with our prescribers.
For reference, the 5 mg dose (one step up from the starter) has its own breakdown of what that pen delivers, on the page about how many units 5 mg of tirzepatide is. Each dose step in the Mounjaro range has a fixed, pre-set delivery mechanism; none of them involve the patient measuring anything in units. If you've already worked through the earlier steps and want to understand the next stages, the page explaining how many units 7.5 mg of tirzepatide corresponds to covers that dose in the same way, and the pages on what 10 units of tirzepatide works out to in mg and what 30 units of tirzepatide works out to in mg address those common conversion queries directly.
Dose questions come up a lot. Prescribers hear them most weeks: someone's pen looks different from last month's, a pharmacist abroad used different terminology, a family member on insulin is trying to help and introduced the units concept. None of that is unusual, and the question deserves a direct answer rather than a vague brush-off.
The right route is your prescriber, not a unit-conversion table. If you're already on Mounjaro and something has changed or feels unclear, the FAQs cover common practical questions, and our aftercare team is available seven days a week through the contact page. If you're still deciding whether Mounjaro is right for you and want to understand how doses work in practice, the Mounjaro overview lays out the full picture (mechanism, schedule, evidence and eligibility) in plain language.
One practical note: if you're planning to start treatment and you're timing your order around a particular week (a long weekend, a bank holiday, or simply wanting it to arrive before a certain date) orders placed before 12pm on a working day go out the same day once clinically approved, with free next-working-day tracked delivery. Worth factoring in if timing matters.
For anyone weighing up the broader treatment landscape, the weight-loss treatment overview sets out what's licensed in the UK and how the options compare. The clinical team profile on our clinical lead's page gives a sense of who reviews consultations.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.